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Abstract
Background: Thirty thousand infants are born every year with congenital hearing impairment in mainland China. Racial and
regional factors are important in clinical diagnosis of genetic deafness. However, molecular etiology of hearing impairment
in the Tibetan Chinese population living in the Tibetan Plateau has not been investigated. To provide appropriate genetic
testing and counseling to Tibetan families, we investigated molecular etiology of nonsyndromic deafness in this population.
Methods: A total of 114 unrelated deaf Tibetan children from the Tibet Autonomous Region were enrolled. Five prominent
deafness-related genes, GJB2, SLC26A4, GJB6, POU3F4, and mtDNA 12S rRNA, were analyzed. Inner ear development was
evaluated by temporal CT. A total of 106 Tibetan hearing normal individuals were included as genetic controls. For
radiological comparison, 120 patients, mainly of Han ethnicity, with sensorineural hearing loss were analyzed by temporal
CT.
Results: None of the Tibetan patients carried diallelic GJB2 or SLC26A4 mutations. Two patients with a history of
aminoglycoside usage carried homogeneous mtDNA 12S rRNA A1555G mutation. Two controls were homozygous for 12S
rRNA A1555G. There were no mutations in GJB6 or POU3F4. A diagnosis of inner ear malformation was made in 20.18% of
the Tibetan patients and 21.67% of the Han deaf group. Enlarged vestibular aqueduct, the most common inner ear
deformity, was not found in theTibetan patients, but was seen in 18.33% of the Han patients. Common molecular etiologies,
GJB2 and SLC26A4 mutations, were rare in the Tibetan Chinese deaf population.
Conclusion: The mutation spectrum of hearing loss differs significantly between Chinese Tibetan patients and Han patients.
The incidence of inner ear malformation in Tibetans is almost as high as that in Han deaf patients, but the types of
malformation vary greatly. Hypoxia and special environment in plateau may be one cause of developmental inner ear
deformity in this population.
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Introduction
Hereditary hearing loss is a genetically heterogeneous disorder
in humans, with an incidence rate of approximately 1 in 1000
children [1]. Nonsyndromic deafness accounts for 60–70% of
inherited hearing impairment cases and involves 114 loci and 66
different genes with autosomal dominant (DFNA), autosomal
recessive (DNFB), X-linked (DFN), and maternal inheritance
patterns [2].
In China, there are 27.80 million people with hearing and
speech disabilities; of these, 20.04 million have simple hearing
disability [3], with genetic factors accounting for about 55% of the
Chinese deaf population of Han ethnicity [3–4]. Worldwide, the
most common causes of nonsyndromic autosomal recessive
hearing loss are mutations in connexin 26, a gap-junction protein
encoded by the GJB2 gene [5–13]. Defects in SLC26A4, which
encodes the anion (chloride/iodide, chloride/bicarbonate) trans-
porter Pendrin, can cause nonsyndromic DFNB4 deafness with
enlargement of the vestibular aqueduct (EVA) and Pendred
syndrome [14,15]. A mutation of SLC26A4 mutation is the second
most common cause of deafness in China [4]. Although the
majority of cases of hereditary hearing loss are caused by nuclear
gene defects, it has become clear that mutations in mitochondrial
DNA (mtDNA) can also cause nonsyndromic hearing loss. The
best studied mutations related to aminoglycoside suscepterblity are
A1555G and C1494T in the mitochondrial 12S rRNA gene [16–
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mutations in GJB2, SLC26A4, or mtDNA 12S rRNA typical
accounts for 33.8% of the cases of deafness in areas of China [4].
China is a multiethnic country. Tibetans live mainly on the
Tibetan Plateau, an area of southwest China with an average
altitude of 4000 m above sea level, making it one of the highest
region in the world. High-altitude hypoxia (reduced inspired
oxygen tension owing to decreased barometric pressure) exerts
severe physiological stress on the human body. Populations living
on the Tibetan Plateau exhibit unique circulatory, respiratory, and
hematological adaptations to life at high altitude, and these
responses have been well characterized physiologically. Recent
studies of the genetics associated with high-altitude adaptation
have facilitated the genotype–phenotype studies necessary to
confirm the role of selection-determined candidate genes and gene
regions involved in adaptation to altitude [19,20]. Although
hearing and vestibular disorders at high altitude have been
reported since 1938, the etiologies of these disorders are still
unknown. The mechanisms by which the auditory system adapts
to high altitude have not been elucidated in detail, and the
molecular etiology of hereditary hearing loss in populations on the
Tibetan Plateau remains unknown.
In the present study, we comprehensively analyzed five
prominent deafness-related genes, i.e., GJB2, SLC26A4, mtDNA
12S rRNA, GJB6, and POU3F4, in 114 Tibetan patients from
unrelated families in the Tibetan Plateau who experienced early-
onset, nonsyndromic hearing impairment, to investigate the
molecular etiology of hereditary hearing loss in this region. All
of the patients underwent temporal computed tomography (CT) to
evaluate inner ear development. In addition, detailed genotype
and phenotype analyses were performed in the Tibetan hearing
loss patients.
Materials and Methods
Patients and DNA samples
A total of 114 Tibetan deaf subjects from unrelated families
were included in this study. They were all from Lhasa Special
Education School, which is the only special education school in
Tibet Autonomous Region. This cohort consisted of 57 males and
57 females ranging in age from 8 to 21 years, with an average age
of 12.1062.75 years. The study protocol was approved by the
ethics committee of the Chinese PLA General Hospital. Written
informed consent was obtained from all subjects or their parents
prior to blood sampling. Parents were interviewed with regard to
age at onset, family history, mother’s health during pregnancy,
and patient’s clinical history, including infection, possible head or
brain injury, and the use of aminoglycoside antibiotics.
All subjects showed moderate to profound bilateral sensorineu-
ral hearing impairment on audiograms. Careful medical exami-
nations revealed no clinical features other than hearing impair-
ment. None of the Tibetan patients with hearing impairment in
our study showed any sign of vestibular dysfunction in their case
history. Using a commercially available DNA extraction kit
(Watson Biotechnologies Inc., Shanghai, China), DNA was
extracted from the peripheral blood leukocytes of the 114 patients
with nonsyndromic hearing loss and the 106 region- and ethnicity-
matched controls with normal hearing.
Mutational analysis
For all patients, the GJB2 coding region plus approximately
50 bp of the flanking intron regions and the mitochondrial 12S
rRNA gene (nt611 to nt2007) were amplified by PCR, followed by
sequence analysis using the Big Dye sequencing protocol with an
ABI 3100 Genetic Analyzer and analysis software v.3.7 NT
(Applied Biosystems, Foster City, CA), according to the manufac-
turer’s protocol. Patients with a monoallelic GJB2 coding region
mutation were further tested for the GJB2 IVS1+1G.A mutation
or defects in exon 1 and the promoter of GJB2. The specific
promoter region of GJB2 includes 128 bp.The basal promoter,-
exon 1 and donor splice site of GJB2 gene can be found in
GenBank (accession number U43932.1); the GJB6 309-kb
deletion; and the mutations of the entire GJB6 coding region.
The presence of the 309-kb GJB6 deletion was analyzed by PCR
[15,16]. A positive control (provided by Balin Wu, Department of
Laboratory Medicine, Children’s Hospital Boston and Harvard
Medical School, Boston, MA) was used to detect GJB6 gene
deletions.
The exons of SLC26A4 of all 114 patients were sequenced
individually, starting with the frequently mutated exons, until two
mutant alleles were identified. The patients verified with an inner
ear malformation on a temporal bone CT scan were further tested
for a POU3F4 gene mutation.
Similarly, the GJB2, SLC26A4, and mtDNA 12S rRNA genes
from 106 Tibetan controls with normal hearing were sequenced to
determine the presence of mutations and exon variants. As no
POU3F4 variants, with the exception of two silent mutations, were
found in the individuals with hearing loss, POU3F4 was not
sequenced in the control group.
CT scan
All 114 patients were examined by temporal bone CT for
diagnosis of EVA or other inner ear malformations, at the General
Hospital of Tibet Military District. The diagnosis of EVA was
based on a diameter of .1.5 mm at the midpoint between the
common crus and the external aperture. For radiological
comparison, the temporal CT results in 120 patients, mainly of
Han ethnicity, with sensorineural hearing loss were analyzed at the
Genetic Testing Center for Deafness of PLA General Hospital.
Results
Among the 114 cases included in this study, 88 had prelingual
hearing loss, including 56 cases of congenital hearing loss. Eight
cases showed postlingual hearing loss, with an average age of onset
of 2.9761.37 years. The age of onset was unclear in the remaining
18 cases. Thirteen cases (8 prelingual and 5 postlingual), with an
average age of onset of 2.0161.18 years, had a clear history of
aminoglycoside administration. Patients with no history of
aminoglycoside usage showed a significantly earlier average age
of onset (0.9261.03 years; P,0.001).
GJB2 gene mutations
Sequence analysis of the GJB2 gene indicated that none of the
Tibetan patients carried two pathogenic mutations. Only two
Tibetan patients carried a confirmed GJB2 heterozygous patho-
genic mutation, c.235delC and c.299_300delAT mutation,
respectively (Table 1). One Han patient carried a heterozygous
c.235delC mutation.
The allele frequency of p.R127H, classified as a pathogenic
GJB2 mutation, was significantly higher in the patient group than
in the control group (P,0.05), indicating that p.R127H may be a
mutation in the Chinese Tibetan hearing loss population.
However, all 15 patients with the p.R127H mutation were
heterozygotes. The pathogenic GJB2 mutation p.R32H was
carried by a control subject, but was not found in the patients.
An unclassified variant, p.T123N, had been counted as a mutation
in a previous Japanese study, but as a polymorphism in studies
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p.T123N alleles in our Tibetan control subjects, but none in the
Tibetan patient group (P.0.05), suggesting that it may be a
neutral variant. The frequency of p.V37I was higher in the deaf
group than in the controls in the present study, but the difference
was not significant (P.0.05). The p.V37I variant was considered a
pathogenic mutation in Japanese, Iranian, Korean, Moroccan,
Malay, Israeli, Australian, and Italian studies [12,23–30], but was
reported as a variant in African-American, Caribbean Hispanic,
French, Chinese, and Thai individuals with hearing impairment
[31–34]. There was no significant difference in the allele frequency
of p.V153I, classified previously as a polymorphism [2], between
the Tibetan patient group and the controls in the present study
(P.0.05), and we regarded it as a polymorphism. The p.V27I,
p.E114G, and p.I203T variants were polymorphisms in the
Chinese populations of Han [13] and Tibetan ethnicity. The GJB2
IVS1+1G to A mutation was not detected in patients with a
heterozygous GJB2 mutation, and no novel nucleotide alterations
were identified in the Tibetan hearing loss patients or control
subjects.
SLC26A4 gene mutations
Six nucleotide changes in the SLC26A4 gene were verified
through sequencing of all 20 exons of the gene from 114 Tibetan
patients (Table 2). None of the Tibetan patients carried an
SLC26A4 mutation on two alleles. Four patients exhibited the
heterozygous c.1826T.G (p.V609G) variant. In addition, four
c.1826T.G heterozygotes were verified in the control group. As
there was no significant difference between the patient and control
groups, we considered this a polymorphism in the Tibetan
population, although Pryor et al. classified it as a mutation in
2005 [2]. The IVS13+9C .T variant was first reported as a splice
site mutation by Yong et al. in 2001 [35]. The IVS13+9C .T
variant was carried by one patient in the heterozygous state in our
study population, and it did not predict a gain or loss of a splice
site when analyzed using the Neural Network Splice Site
Prediction Tool NNSPLICE0.9 (available at http://www.fruitfly.
org/seq_tools/splice.html). Therefore, we considered this to be a
benign variant.
Two patients carried novel unclassified missense variants of
SLC26A4, c.757A.G (p.I253V) and c.1522A.G (p.T508A),
respectively. We found four p.I253V heterozygotes, but no
p.T508A carriers in the control group. The frequency of
p.I253V was higher in the control group than in the patient
group (P.0.05). No p.I253V allele was found in 100 normally
hearing individuals of Han ethnicity (unpublished data). Thus, we
considered it to be a polymorphism typical of the Tibetan Chinese
population.
Both c.273A.T (p.G91G) and c.753C.T (p.L251L) are silent
variants of SLC26A4. The intron18-56delCAAA was considered to
be an intron variant.
Table 1. Genotypes of GJB2 gene in Tibetan patients with hearing loss and Tibetan controls.
Allele 1 Allele 2
numbers
found in
patients
numbers
found in
controls
Nucleotide
Change
Consequence or
amino acid change Category
Nucleotide
change
Consequence or
amino acid Change Category
c.235delC Frameshift TM2 Pathogenic 10
c.299_300delAT Frameshift IC2 Pathogenic 10
c.341A.G p.E114G IC2 Polymorphism c.79G.A,
c.341A.G
p.V27I,p.E114G Polymorphism 1 0
c.79G.A p.V27I Polymorphism c.79G.A,
c.341A.G
p.V27I,p.E114G Polymorphism 3 1
c.79G.A, c.341A.G p.V27I,p.E114G Polymorphism - 15 24
c.79G.A, c.341A.G p.V27I,p.E114G Polymorphism c.79G.A,
c.341A.G
p.V27I,p.E114G Polymorphism 2 1
c.341A.G p.E114G Polymorphism 1 0
c.79G.A p.V27I TM1 Polymorphism 15 16
c.79G.A p.V27I Polymorphism c.79G.A p.V27I Polymorphism 1 3
c.79G.A p.V27I Polymorphism c.380G.A p.R127H Pathogenic 3 0
c.79G.A p.V27I Polymorphism c.368C.A p.T123N IC2 Polymorphism 0 2
c.380G.A p.R127H IC2 Pathogenic c.79G.A,
c.341A.G
p.V27I,p.E114G Polymorphism 6 0
c.380G.A p.R127H Pathogenic c.457G.A p.V153I TM3 Polymorphism 1 0
c.380G.A p.R127H Pathogenic 50
c.109G.A
cp.V37I, TM1
cSee note 10
c.109G.A
cp.V37I
cSee note c.380G.A p.R127H Pathogenic 1 0
c.608T.C p.I203T TM4 Polymorphism 1 2
c.95G.A p.R32H TM1 Pathogenic 01
c.438C.T p.F146F TM3 Polymorphism 2 1
TM, transmembrane domain; EC, extracellular domain; IC, intracellular domain.
Note: p.V37I is controversy variant, see the discussion.
doi:10.1371/journal.pone.0030720.t001
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Two Tibetan patients and two normal hearing Tibetan controls
carried a homogeneous mtDNA 12S rRNA A1555G mutation.
Neither the C1494T mutation nor any other 12S rRNA mutation
associated with hearing impairment, including nucleotide changes
at positions 961 and 1095, were found in the Tibetan patient or
control groups.
POU3F4 mutations
No POU3F4 mutations, with the exception of the two
polymorphisms 708A.G (E236E) and 710G.C (E236E), were
identified in the 23 patients with inner ear malformation.
Temporal bone CT scan
Nine types of inner ear malformations were verified on temporal
bone CT scans in 23 Tibetan patients (a total of 37 ears) (Table 3).
The frequency of inner ear malformation in the Tibetan hearing-
loss patients was 20.18% (23/114). EVA, the most common type
of inner ear malformation in China reported in previous studies,
was not detected in the Tibetan deafness patients in the present
study. The results of temporal CT in 120 patients, mainly of Han
ethnicity, with sensorineural hearing loss revealed that 21.67%
(26/120) had an inner ear malformation, 18.33% (22/120) had
EVA, and only 3.33% (4/120) showed other types of inner ear
malformations, including hypoplastic cochlea, hypoplastic vestib-
ular aqueduct, incomplete partition type I, and common cavity
(Fig. 1).
Discussion
According to the second nationwide survey of the disabled
Chinese population performed in 2006, there were 27.80 million
people with hearing and speech disabilities in China. The number
of Chinese with hearing disability alone is 20.04 million,
representing 1.54% of the population (20.04 million/1300
million). The percentage of the population with hearing disability
in the Tibet Autonomous Region is 1.65% [36]. More than 92%
of the whole population in the Tibet Autonomous Region is
Tibetan, and 93.4% of the patients in our study population were
Tibetan. Despite a similar incidence of moderate to profound
sensorineural hearing loss in the Tibetan and Chinese populations,
the molecular etiology in Tibetan patients appeared differ
markedly from that in the Chinese population as a whole based
on the present results. We found no homozygous or compound
heterozygous mutations of the GJB2 or SLC26A4 gene. The
mtDNA 12S rRNA A1555G homogeneous mutation and the use of
aminoglycoside antibiotics were responsible for hearing loss in
1.75% (2/114) of the Tibetan patients. In typical areas of China,
GJB2 gene mutations account for the etiology in about 18.31% of
patients with hearing loss, SLC26A4 mutations account for about
13.73%, and the 12S rRNA A1555G mutation accounts for 1.76%
[4]. There is no significant difference in the 12S rRNA A1555G
mutation rate between the Tibetan patients with hearing
impairment and the patients mainly of Han ethnicity.
The pathogenicity of the GJB2 p.V37I mutation is controver-
sial. In a multicenter study, p.V37I was shown to be associated
with mild to moderate hearing impairment (median, 25–40 dB)
[37]. Our recent study indicated p.V37I had an allele frequency of
6.7% (185/2744) in a Han patient group (excluding all cases with
two clearly pathogenic mutations), and this was significantly higher
than that in a control population (2.8%, 17/602; P=0.0003) [13],
supporting Wu’s suggestion that p.V37I should be reassigned from
an allele variant to a pathogenic mutation [38]. In the present
study, the frequency of p.V37I was higher in Tibetan patients with
hearing loss than in ethnicity-matched controls, but the difference
was not significant (P.0.05). Since our sample size was still too
small to reach a confident statistical conclusion.and only two of
our Tibetan patients carried GJB2 p.V37I (table 1), our results
didn’t support that p.V37I was pathogenic in Tibetan Chinese
patients. Alternative explanation may be another unknown
mutation associated with the V37I mutation is responsible for
the etiology of Tibetan Chinese patients with hearing loss.
POU3F4 has been identified only for the Locus DFN3. The
clinical features of DFN3 often include mixed progressive hearing
loss, temporal bone anomalies, and stapes fixation [39–41].
POU3F4 belongs to a subfamily of transcription factors charac-
terized by two conserved DNA-binding domains, a POU and a
HOX domain, containing a helix-turn-helix structural DNA-
binding motif. Several reports have described POU3F4 mutations
in patients with hearing loss and temporal bone abnormalities
[42]. Temporal bone CT scans of DFN3 patients as well as the
Pou3f4 knockout inner ear phenotypes have suggested that most of
Table 2. Genotypes and phenotype of SLC26A4 gene in Tibetan patients with hearing loss.
Allele 1 Allele 2
numbers
found in
patients
Tempornal bone
CT scan phenotype
Nucleotide Change
Amino acid
change Category
Nucleotide
change
Amino acid
change Category
c. 1826T.G p.V609G Polymorphism intron18-56delCAAA intron variant 1 hypoplastic cochlea,
enlargement of IAC
c. 1826T.G p.V609G Polymorphism intron18-56delCAAA intron variant 3 nl
c.273A.T p.G91G Silent variant . 1 Stenosis of IAC
c.753C.T p.L251L Silent variant 1 nl
c.757A.G p.I253V Polymorphism 1 hypoplastic cochleavestibular
and semicircular canals
c.1522A.G p.T508A Less likely be Pathogenic
or exon variant
1n l
IVS13+9C.T aberrant splicing intron variant 1 nl
nl, normal; EVA, enlarged vestibular aqueduct; IVS7, intravening sequence 7 (intron 7); IVS13, intravening sequence 13 (intron 13);IVS15, intravening sequence 15 (intron
15);IVS18, intravening sequence 18 (intron 18);IAC,internal auditory canal.
doi:10.1371/journal.pone.0030720.t002
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mesenchyme [43,44]. However, no variants or mutations were
found in Tibetan patients recruited in this study with inner ear
malformation.A series of transcription factors, including Pax2, Six,
Eya1, Dlx, Hmx2–3, GATA3, RA, Otx1–2, IGF-1, and Tbx1, are
related to the development of the mammalian otic capsule, and
defects in these factors were reported to cause inner ear
deformities in mice [45–54]. As the phenotype and genotype
correlations for these genes in human patients with inner ear
malformation are not clear, we did not screen for these genes in
our patients.
The inner ear malformations in our Tibetan patients were
diverse and severe. EVA, the most common inner ear deformity,
was not found in our cases. This radiological finding was consistent
with the genetic analyses, as no diallelic mutations were found in
the open reading frame of SLC26A4. A novel SLC26A4 variant,
Figure 1. CT images of inner ear malformation in Tibetan patients with hearing impairment. a. incomplete partition type I b. common
cavity deforrmity c. malformation of inner ears including cochlea,vestibular and semicircular canals d. malformation of cochlea and enlargement of
internal auditory canals e. narrow internal auditory canal f. malformation of vestibular and semicircular canals g. malformation of semicircular canals
h. malformation of cochlea i. ossification of the inner ear.
doi:10.1371/journal.pone.0030720.g001
Table 3. Temporal bone CT Scan Phenotype in Chinese Tibetan patients with hearing loss.
Phenotype numbers found in patients Numbers of ears found in patients
a incomplete partition type I 1 1
b common cavity deforrmity
c11
c malformation of inner ears including cochlea,vestibular and semicircular canals 10 18
d malformation of cochlea and enlargement of internal auditory canals 1 2
e narrow internal auditory canal 3 6
f malformation of vestibular and semicircular canals 5 6
g malformation of semicircular canals 1 1
h malformation of cochlea 1 1
i ossification of the inner ear 1 1
j enlarged vestibular aqueduct 0 0
Note:One patient shows common cavity deforrmity in the right ear and incomplete partition type I in the left ear.
doi:10.1371/journal.pone.0030720.t003
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location of this amino acid in an evolutionarily conserved region
implies that its substitution may result in a structurally and/or
functionally different protein. We then carried a SIFT analysis on
SLC26A4 p.T508A variant.The SIFT score was 0.17 and the SIFT
prediction result was that the amino acid change was tolerated,-
which indicated it may be only a variant or be less likely a
pathogenic mutation.There are two types of inner ear malforma-
tion: osseous labyrinth deformity and membranous labyrinth
deformity. We assessed only the osseous labyrinth shape by high-
resolution temporal bone CT. Magnetic resonance imaging (MRI)
and water image of the inner ear may be valuable for assessment of
membranous labyrinth deformity. However, we did not perform
these two radiological examinations and could not evaluate the
membranous labyrinth. Whether malformation of vestibular and/
or semicircular canals can cause hearing-related phenotypes is not
certain, but imbalances of the ion environment in the cochlea as
well as structural abnormalities can result in hearing impairment.
Hearing loss caused by EVA is an example of a pathology with
normal cochlear structure, but with a suggested cochlear ion
imbalance.
To our knowledge, there have been no previous studies of the
genetic etiology of hearing loss in Tibetan patients. The distinct
mutational spectrum of common hearing-related genes in the
Tibetan patients compared with typical patients in other areas of
China may be explained by ethnic and regional factors. According
to archeological data, the Tibetan Plateau was first populated
approximately 25,000 years ago. Compared with low-altitude
populations, the populations indigenous to the high-altitude zones
possess unique physiological characteristics [55]. Some of the
environmental hardships at high altitudes include, but are not
limited to, decreased ambient oxygen tension, increased solar
radiation, extreme diurnal ranges in temperature, arid climate,
and poor soil quality. The incidence of congenital heart disease
including patent ductus arteriosus,ventricular septal defect,ven-
tricular septal defect, atrial septal defect and valvular insufficiency
in the Tibetan plateau is 0.615%.It is higher than that in lower
altitude areas in China,which is 0.31% in Chengdu from Sichuang
Province, 0.239% in Hefei from Anhui Province and 0.28% in
Fuzhou from Fujian Province,respectively [56]. And with the
increase of altitude in the same province,the incidence of
congenital heart disease is increasing,which indicated that anoxia
in high altitude area was regarded as one of the enviromental
factors related with congenital heart disease [57]. Several studies
have shown that Tibetan populations have lower hemoglobin
concentrations than lowland Chinese populations [58]. Related
studies have explored the heritability of specific altitude-related
phenotypes, such as arterial oxygen saturation and hemoglobin
concentration [58–60]. One heritability study concluded that there
is a major autosomal dominant locus for high oxygen saturation,
and Tibetan women carrying this high oxygen-saturation allele
had higher offspring survival than those with a low oxygen-
saturation allele [59]. In addition, positively selected haplotypes of
EGLN1 and PPARA were significantly associated with the
decreased hemoglobin phenotype unique to this highland
population [20]. The genetic evidence for high-altitude adaptation
in Tibet suggests that epigenetic regulation may play a greater role
in the physiopathological process in Tibetans, although this has yet
to be confirmed. High-altitude hypoxia exerts severe physiological
stress on the human body, including embryonic auditory organ
development.
Conclusion
The results of the present study indicate that the mutation
spectrum of Tibetan Chinese patients with hearing loss is
significantly different from that seen in patients of Han ethnicity.
The incidence of inner ear malformation in the Tibetan Chinese
population is almost as high as that in Chinese Han patients, but
the types of malformation vary greatly in the Tibetan population.
The most common inner ear deformity, enlarged vestibular
aqueduct (EVA), is rare in the Chinese Tibetan hearing-loss
population. Hypoxia may be one of the causes for the
development of inner ear deformity, but further studies are
required to determine the genetic etiology of hearing loss in
Tibetan patients.
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